Allogene Therapeutics, Inc. · NASDAQ:ALLO

David D. Chang, M.D., Ph.D. reported a 5.20% stake in Allogene Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Feb 13, 2026

David D. Chang, M.D., Ph.D. reported a 5.20% stake in Allogene Therapeutics, Inc., 12,101,223 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G).

Stake
5.20%
Shares
12,101,223
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
David D. Chang, M.D., Ph.D.5.20%12,101,223
Chang 2006 Family Trust0.50%1,201,108
JEC 2019 Trust0.40%856,044
RTC 2019 Trust0.40%856,044

Source

View original at SEC

Related